Tivic Announces 2024 Annual Meeting of Stockholders

Rhea-AI Summary

Tivic Health Systems, Inc. (Nasdaq: TIVC), a bioelectronic medicine company, has announced its 2024 Virtual Annual General Meeting of Shareholders. The meeting is scheduled for Friday, August 9, 2024, at 10:00 a.m. Pacific Time. Stockholders of record as of June 17, 2024, are eligible to attend and vote. The virtual format aims to provide a consistent and convenient experience for all stockholders.

To participate, stockholders will need to use the control number provided on their Notice or proxy card. Beneficial owners without a control number can access the meeting through their brokerage firm's website. The company's Proxy Statement and Annual Report on Form 10-K for 2023 are available on Tivic Health's investor relations website.

SAN FRANCISCO--(BUSINESS WIRE)-- Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the Virtual Annual General Meeting of Shareholders will be held on Friday, August 9, 2024 at 10:00 a.m., Pacific Time. The Company has adopted a virtual format for our Annual Meeting to provide a healthy, consistent, and convenient experience for all stockholders regardless of location.

			WHEN:	Friday, August 9, 2024
			TIME:	10:00 AM Pacific Time
			WHERE:	www.virtualshareholdermeeting.com/TIVC2024

Only stockholders of record at the close of business on June 17, 2024 are entitled to notice of, and to vote at, the Annual Meeting. To attend online and participate in the Annual Meeting, stockholders of record will need to use the control number included on the Notice or proxy card they received in the mail to log into the Annual meeting. Beneficial owners who do not have a control number may gain access to the Annual Meeting by logging into their brokerage firm’s website and selecting the stockholder communication mailbox to link through to the Annual Meeting. Instructions should also be provided on the voting instruction card provided by their broker, bank, or other nominee.

The company’s Proxy Statement and Annual Report on Form 10-K for the year ended December 31, 2023 are both available on the Internet at: https://tivichealth.com/investor/#SEC.

About Tivic Health

Tivic Health is a commercial health tech company advancing the field of bioelectronic medicine. Tivic Health’s technology platforms leverage stimulation of the trigeminal, sympathetic, and vagus nerve structures. Tivic Health’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic Health’s first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. For more information visit http://tivichealth.com @TivicHealth.

Forward-Looking Statements

This press release may contain “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of risks and uncertainties relevant to the company, and other important factors, see Tivic Health’s filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 29, 2024, under the heading “Risk Factors”; as well as the company’s subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240802349967/en/

Media Contact:

Morgan Luke

Morgan.Luke@tivichealth.com

Investor Contact:

Hanover International, Inc.

ir@tivichealth.com

Source: Tivic Health Systems, Inc.

FAQ

When is Tivic Health's (TIVC) 2024 Annual Meeting of Stockholders?

Tivic Health's (TIVC) 2024 Annual Meeting of Stockholders is scheduled for Friday, August 9, 2024, at 10:00 a.m. Pacific Time.

How can shareholders attend Tivic Health's (TIVC) 2024 virtual Annual Meeting?

Shareholders can attend Tivic Health's (TIVC) 2024 virtual Annual Meeting by visiting www.virtualshareholdermeeting.com/TIVC2024 and using their control number provided on the Notice or proxy card.

What is the record date for Tivic Health's (TIVC) 2024 Annual Meeting?

The record date for Tivic Health's (TIVC) 2024 Annual Meeting is June 17, 2024. Stockholders of record at the close of business on this date are entitled to notice of and to vote at the Annual Meeting.

Where can investors find Tivic Health's (TIVC) 2023 Annual Report and Proxy Statement?

Investors can find Tivic Health's (TIVC) 2023 Annual Report and Proxy Statement on the company's investor relations website at https://tivichealth.com/investor/#SEC.